Cargando…

Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions

Background: Schizophrenia is among the major causes of disability worldwide and the mortality from cardiovascular disease (CVD) is significantly elevated. There is a growing concern that this health challenge is not fully understood and efficiently addressed. Methods: Non-systematic review using sea...

Descripción completa

Detalles Bibliográficos
Autores principales: Ringen, Petter Andreas, Engh, John A., Birkenaes, Astrid B., Dieset, Ingrid, Andreassen, Ole A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175996/
https://www.ncbi.nlm.nih.gov/pubmed/25309466
http://dx.doi.org/10.3389/fpsyt.2014.00137
_version_ 1782336557215121408
author Ringen, Petter Andreas
Engh, John A.
Birkenaes, Astrid B.
Dieset, Ingrid
Andreassen, Ole A.
author_facet Ringen, Petter Andreas
Engh, John A.
Birkenaes, Astrid B.
Dieset, Ingrid
Andreassen, Ole A.
author_sort Ringen, Petter Andreas
collection PubMed
description Background: Schizophrenia is among the major causes of disability worldwide and the mortality from cardiovascular disease (CVD) is significantly elevated. There is a growing concern that this health challenge is not fully understood and efficiently addressed. Methods: Non-systematic review using searches in PubMed on relevant topics as well as selection of references based on the authors’ experience from clinical work and research in the field. Results: In most countries, the standardized mortality rate in schizophrenia is about 2.5, leading to a reduction in life expectancy between 15 and 20 years. A major contributor of the increased mortality is due to CVD, with CVD mortality ranging from 40 to 50% in most studies. Important causal factors are related to lifestyle, including poor diet, lack of physical activity, smoking, and substance abuse. Recent findings suggest that there are overlapping pathophysiology and genetics between schizophrenia and CVD-risk factors, further increasing the liability to CVD in schizophrenia. Many pharmacological agents used for treating psychotic disorders have side effects augmenting CVD risk. Although several CVD-risk factors can be effectively prevented and treated, the provision of somatic health services to people with schizophrenia seems inadequate. Further, there is a sparseness of studies investigating the effects of lifestyle interventions in schizophrenia, and there is little knowledge about effective programs targeting physical health in this population. Discussion: The risk for CVD and CVD-related deaths in people with schizophrenia is increased, but the underlying mechanisms are not fully known. Coordinated interventions in different health care settings could probably reduce the risk. There is an urgent need to develop and implement effective programs to increase life expectancy in schizophrenia, and we argue that mental health workers should be more involved in this important task.
format Online
Article
Text
id pubmed-4175996
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-41759962014-10-10 Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions Ringen, Petter Andreas Engh, John A. Birkenaes, Astrid B. Dieset, Ingrid Andreassen, Ole A. Front Psychiatry Psychiatry Background: Schizophrenia is among the major causes of disability worldwide and the mortality from cardiovascular disease (CVD) is significantly elevated. There is a growing concern that this health challenge is not fully understood and efficiently addressed. Methods: Non-systematic review using searches in PubMed on relevant topics as well as selection of references based on the authors’ experience from clinical work and research in the field. Results: In most countries, the standardized mortality rate in schizophrenia is about 2.5, leading to a reduction in life expectancy between 15 and 20 years. A major contributor of the increased mortality is due to CVD, with CVD mortality ranging from 40 to 50% in most studies. Important causal factors are related to lifestyle, including poor diet, lack of physical activity, smoking, and substance abuse. Recent findings suggest that there are overlapping pathophysiology and genetics between schizophrenia and CVD-risk factors, further increasing the liability to CVD in schizophrenia. Many pharmacological agents used for treating psychotic disorders have side effects augmenting CVD risk. Although several CVD-risk factors can be effectively prevented and treated, the provision of somatic health services to people with schizophrenia seems inadequate. Further, there is a sparseness of studies investigating the effects of lifestyle interventions in schizophrenia, and there is little knowledge about effective programs targeting physical health in this population. Discussion: The risk for CVD and CVD-related deaths in people with schizophrenia is increased, but the underlying mechanisms are not fully known. Coordinated interventions in different health care settings could probably reduce the risk. There is an urgent need to develop and implement effective programs to increase life expectancy in schizophrenia, and we argue that mental health workers should be more involved in this important task. Frontiers Media S.A. 2014-09-26 /pmc/articles/PMC4175996/ /pubmed/25309466 http://dx.doi.org/10.3389/fpsyt.2014.00137 Text en Copyright © 2014 Ringen, Engh, Birkenaes, Dieset and Andreassen. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Ringen, Petter Andreas
Engh, John A.
Birkenaes, Astrid B.
Dieset, Ingrid
Andreassen, Ole A.
Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions
title Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions
title_full Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions
title_fullStr Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions
title_full_unstemmed Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions
title_short Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions
title_sort increased mortality in schizophrenia due to cardiovascular disease – a non-systematic review of epidemiology, possible causes, and interventions
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175996/
https://www.ncbi.nlm.nih.gov/pubmed/25309466
http://dx.doi.org/10.3389/fpsyt.2014.00137
work_keys_str_mv AT ringenpetterandreas increasedmortalityinschizophreniaduetocardiovasculardiseaseanonsystematicreviewofepidemiologypossiblecausesandinterventions
AT enghjohna increasedmortalityinschizophreniaduetocardiovasculardiseaseanonsystematicreviewofepidemiologypossiblecausesandinterventions
AT birkenaesastridb increasedmortalityinschizophreniaduetocardiovasculardiseaseanonsystematicreviewofepidemiologypossiblecausesandinterventions
AT diesetingrid increasedmortalityinschizophreniaduetocardiovasculardiseaseanonsystematicreviewofepidemiologypossiblecausesandinterventions
AT andreassenolea increasedmortalityinschizophreniaduetocardiovasculardiseaseanonsystematicreviewofepidemiologypossiblecausesandinterventions